Abbreviations

1
The abbreviations used are BEL; bromoenol lactone: BSA; bovine serum albumin: CCCP; carbonyl cyanide m-chlorophenylhydrazone: CSA; cyclosporin A: FAME; fatty acid methyl esters: FFA; free fatty acids: iPLA 2 ; Ca 2+ -independent phospholipaseA 2 : sn-1; position 1 within a glycerophospholipid molecule as defined by the stereo specific numbering system: sn-2; position 2 within a glycerophospholipid molecule as defined by the stereo specific numbering system: TMPD; N,N,N'N'-tetramethylphenylenediamine: TPP Relationships between phospholipase activity in mitochondria and degradation of the structure and bioenergetic capacities of these organelles were already under investigation during the 1950s and 1960s
[e.g. (1) (2) (3) ]. Towards the end of that period Waite and coworkers described an apparent relationship between mitochondrial swelling and the activity of an endogenous phospholipase A (4) . Evidence for such a relationship grew stronger during the subsequent decade (5,6), and during the same period the loss of coupled function which accompanied swelling became known as the mitochondrial permeability transition. There was a tendency to interpret results in that emerging area within the context of energy coupling mechanisms underlying the synthesis of ATP (7-9), as being related to the process of Ca 2+ release from mitochondria (10,11), or to the control of steroid hormone biogenesis in cell types having that capacity (12,13).
Attempts to purify and characterize the phospholipase of interest led to the description of a low molecular weight phospholipase A 2 that requires Ca 2+ (14-16) and is subject to inhibition by a product, monolysocardiolipin (17) . Its enzymatic properties, together with cloning and sequencing data, led to classification of the enzyme as a type IIA secretory phospholipase (16, 18) . However, the occurrence of the enzyme in mitochondria from hepatocytes was later called into question and it was thought ultimately that it is present primarily in the Kupfer cells of liver (19, 20) . This latter view raised again the question of the identity of the apparent phospholipase A 2 activity in hepatocyte mitochondria and how it is related to the occurrence of the mitochondrial permeability transition and related phenomena.
The way in which phospholipase A 2 activity might promote the permeability transition became more apparent as evidence accumulated showing that small amounts of free fatty acids promote opening of the permeability transition pore and related phenomena (21) (22) (23) (24) (25) . The question of enzyme identity was illuminated, in part, when it was found that rat liver mitochondria contain a phospholipase A 2 that does not require Ca 2+ while appearing to be much larger than the type IIA secretory enzyme that was of interest before. Based on sensitivity of enzyme activity to bromoenol lactone (BEL) but not to other phospholipase inhibitors, the absence of a Ca 2+ requirement, and its apparent recognition by a commercial antibody raised against partial sequence from a phospholipase found in a macrophage-like cell line, we concluded that the predominate activity is an iPLA 2 (26,27) . Independent work has shown that an analogous enzyme is found in heart mitochondria (28) , the mitochondria of kidney (29) (30) (31) ) and brain (32) , and in those of lung and spleen (33) .
The iPLA 2 activity of rat liver mitochondria acting upon endogenous phospholipids is regulated in some manner by the energetic status of the organelle. That is to say, little or no activity is seen when by guest, on October 22, 2017
www.jlr.org Downloaded from mitochondria are intact and fully energized. The enzyme becomes active upon the addition of a protonophoric uncoupler (CCCP), when the permeability transition pore is opened, or when they are permeabilized by the pore forming compound alamethicin (26,27). Here we investigate the origin of this energy dependence in greater detail, including the relationship between activity and the redox status of individual respiratory chain complexes, the effect of partial deenergization on activity, and the reversibility of enzyme activation brought about by restoring the energetic state.
EXPERIMENTAL PROCEDURES
Preparation and incubation of mitochondria. Rats were maintained by University Laboratory
Animal Resources, and all procedures were approved by the Institutional Animal Care and Use
Committee of the Ohio State University. Briefly, the rats were sacrificed by an overdose of Nembutal that was administered IP. When they were no longer responsive, the abdominal and chest cavities were opened with scissors; the liver was removed, and was then transferred to ice cold isolation medium.
Rat liver mitochondria were prepared by a standard procedure in which bovine serum albumin (BSA) and EGTA were present in the homogenization medium but were absent from the medium used for washing (34) . They were incubated at 25°C in media containing 0.23 M mannitol, 0.07 M sucrose, and 3 mM Hepes (Na + ), pH 7.4, before the addition of respiratory substrates. 10 mM each of glutamate and malate, both Na + salts, were normally used as the substrate but in some cases respiration was supported by 10 mM of Na + succinate, or by 6 mM ascorbic acid in the presence of 100 µM N,N,N',N'-tetramethyl-phenylenediamine (TMPD). When succinate alone was the exogenous substrate, rotenone was present at 1 nmol/mg protein. For all substrates, as they were added to the media, the concentrations of mannitol and sucrose were reduced in proportion to maintain a total osmotic pressure of 300 mOsM.
Incubations were conducted in vessels that were open to the atmosphere, with stirring maintained to provide an availability of O 2 throughout the time course (35) . Because the experiments were conducted over relatively long time frames (up to 2 hours) all incubations pertaining to a given experiment were conducted simultaneously to prevent variations arising from aging of the preparation. Cyclosporin A was always present to prevent occurrence of the permeability transition and the effectiveness of this reagent was verified by monitoring swelling using a Brinkman probe colorimeter that was interfaced to a computer. Alternatively, swelling was sometimes monitored discontinuously using the same instrument, by moving the probe from vessel to vessel and manually recording the reading.
Changes in membrane potential were also of interest and were monitored in parallel with other by guest, on October 22, 2017
www.jlr.org Downloaded from parameters using a TPP + electrode as previously described (35) . For calculation of the potential in units of mV, the matrix volume was taken to be 1 µl/mg protein (36) and the fraction of TPP + bound nonspecifically to mitochondrial components was accounted for (37) . Expected redox states of complex 4 (cytochromes aa 3 ) were verified by dual wavelength spectroscopy (38) . Protein concentrations were determined by the Biuret reaction in the presence of 1% deoxycholate, while oxygen consumption was monitored with a Clark-type electrode.
Determination of iPLA 2 activity: Recently distilled solvents were used throughout. Phospholipase activity was determined by monitoring the accumulation of free fatty acids (FFA) derived from the endogenous phospholipids (34) . To extract these products, a 3 mL aliquot of the incubation was added to 4 mL of cold methanol to which 5.00 g of heptadecanoic acid (17:0) had previously been added as an internal standard. The aqueous methanol solution was mixed before addition of 8 mL CHCl 3 , and the resulting mixture was centrifuged to separate the organic and the aqueous phases. The aqueous phase (upper phase) was removed by aspiration, after which the lower organic phase was transferred to a 10 mL conical screw cap tube. This phase was brought to dryness under N 2 and the free fatty acids were converted to methyl esters (FAME) by reaction with diazomethane (39) . During this procedure, the dried lipid phase was taken up in 1.1 mL of ether: methanol (10:1) to which 0.2 mL of the diazomethane solution was added. Reaction was allowed to continue for 15 minutes at room temperature. The samples were then brought to dryness and taken up in 1 mL hexane. Typically they were thereafter stored overnight, at -80 C and under argon, prior to analysis by GLC.
To begin the analysis the stored samples were dried and the lipids were taken up in 0.2 mL hexane.
These solutions were applied to silica gel mini columns for the separation of FAME from other mitochondrial lipids (34) . The columns were washed successively with 1.0 mL hexane, 1.8 mL CHCl 3 and finally 2.0 mL hexane:ether (1:1). FAME are obtained in the hexane:ether wash. The hexane:ether solvent mixture was removed under N 2 and the FAME were taken up in 12 L of hexane. They were separated and quantitated using a GLC equipped with a capillary column and a computing integrator. All experiments were repeated twice, and in most cases three times, with the data shown being representative.
RESULTS
Effects of electron transport inhibitors;
In principle, activation of the iPLA 2 upon deenergizing mitochondria could reflect a direct effect of table) . In addition, rotenone leads to deenergization of mitochondria under these conditions, similar to the effect of the uncoupler CCCP (figure 2, Rotenone and CCCP). As seen in figure 1A , in mitochondria oxidizing glutamate plus malate the iPLA 2 is active when rotenone is present, and the activity level is the same as when CCCP is present. These findings are consistent with the notion that the iPLA 2 is activated by deenergization per se, but as already noted, mitochondrial components change their redox state upon deenergization, and it might be that it is the state of these that is actually affecting the enzyme. Among the various possibilities figure 1A tends to rule out an important role for the redox state of complex 1 because it will be reduced when rotenone is present but (substantially) oxidized in the presence of CCCP.
To further probe for possible effects of redox state on iPLA 2 activity we examined the effects of antimycin A, which inhibits electron transport at complex 3 (scheme 1). As seen in figure 1B, this agent also activates the enzyme. It is equally effective compared to rotenone in this regard and in promoting loss of membrane potential (figure 2, Antimycin A). Antimycin A, like rotenone, will cause a persistent reduction of complex 1 in the presence of an NAD + linked substrate and will also produce a persistent reduced state of complex 3. Thus it would seem that as with complex 1, there is also no special role for the redox state of complex 3 in regulating the iPLA 2 since equal activity is seen when complex 3 is oxidized (rotenone present, antimycin absent) and when it is reduced (rotenone absent, antimycin A present).
Cyanide blocks electron transport at complex 4, resulting in reduction of the entire electron transport chain while also maintaining a state of deenergization (figure 2, KCN). Like the other inhibitors employed to this point, the iPLA 2 is active when cyanide is present ( figure 1C ).
The enzyme is also active when succinate plus rotenone is used as substrate and TTFA is present Thus, the iPLA 2 in liver mitochondria becomes active upon deenergization, regardless of what redox states in the electron transport chain are maintained by the agents used to produce deenergization.
Oligomycin, which inhibits complex 5 (the ATP synthase complex) and so leads to depletion of ATP in the matrix space, has no effect on iPLA 2 activity (figure 1 E) or on mitochondrial membrane potential under these conditions (figure 2, Oligomycin).
Reversibility and partial activation;
As further discussed below, one can imagine several physiological or pathophysiological processes wherein the energy dependence of mitochondrial iPLA 2 activity might be of significance. These possibilities are perhaps best considered within the context of whether or not activation of the enzyme is reversible, and in light of a more detailed understanding of the relationship between the extent of deenergization and the magnitude of enzyme activity. To examine the potential for reversibility, mitochondria oxidizing glutamate plus malate were deenergized with rotenone and maintained in that state for a period of 60 min. Succinate was then added to reestablish electron flow below complex 1 and by guest, on October 22, 2017
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There was furthermore a reduction in the preexisting level of free fatty acids which occurred during further incubation. These findings were confirmed by using antimycin A to produce deenergization and subsequently adding the artificial electron carrier TMPD in the presence of ascorbic acid. Those conditions reestablish electron flow to complex 4 and reestablished a significant membrane potential as expected ( figure 4B ). This membrane potential was also sufficient to thereafter limit activity of the iPLA 2 and a reduction in the preexisting level of free fatty acids was again observed (figure 5B) 4 .
To investigate how a partial loss of membrane potential affects iPLA 2 activity methods were needed to generate various degrees of deenergization and to sustain these over an extended period. The activity of malonate as an inhibitor of succinate oxidation can be used in both regards, as illustrated in figures 6A and 6B. Increasing the concentration of malonate progressively decreases the succinate oxidase activity of respiring mitochondria with a half maximal effect seen at about 3 mM, and a maximal effect at about 15 mM, when the succinate concentration is 10 mM (figure 6A). As the succinate oxidase activity falls, the membrane potential also falls following a lag that is apparent at the lowest malonate concentrations employed. This lag in the concentration dependence can be attributed to the need for less than the available succinate oxidase activity to maintain a full potential when mitochondria are not under a significant load, but more importantly it is seen that the partially reduced membrane potentials produced at intermediate levels of malonate are stable for periods of 2 hrs or longer when an open incubation vessel is employed ( figure 6B ). This time frame allowed us to compare activity to membrane potential when the latter parameter was suppressed to different degrees. As seen in figure 6C , there is a clear relationship between these parameters wherein a partially reduced membrane potential produces a partial activation of the iPLA 2 that is maintained over time. In more detail, decreasing the membrane potential from about 170 mV to about 130 mV was sufficient to activate the iPLA 2 to ½ of the maximal activity. Presuming that the same situations pertain in vivo one can imagine that relatively modest energy loads would bring forth some activity of the iPLA 2 which would return to the resting, no activity level, when the energy load was dissipated.
Inhibition of induced activities by BEL:
The effectiveness of BEL as an inhibitor of activity induced by the various inhibitors used here was also examined. As seen in figure 7, BEL was equally effective with all of them, while the fraction of activity inhibited was limited to ~50%. The inhibited fraction was not increased by using higher levels of BEL, by making a second addition at 1hr after the first, by using the (R) and (S) BEL enantiomers 
DISCUSSION
As documented in the Introduction, there has been considerable effort directed at determining which proteins are responsible for releasing fatty acids from mitochondrial phospholipids. It is also important to understand how the process is regulated biochemically as investigate here. In our preceding papers describing iPLA 2 activity in liver mitochondria, we emphasized that deenergization is required to activate the enzyme (26,27). Chemical uncoupling, pore formation, and ion transport loads were emphasized as the approaches to deenergization. We can now add to this group a number of electron transport inhibitors, all of which are equally effective, and as effective as the approaches used earlier.
This is significant because each of the agents used produce well-understood states of the electron transport chain in which the individual complexes are highly reduced or highly oxidized during It is first of all clear that small molecule effectors involved in activation would have to be inhibitors rather than activators. This is because activation by opening the permeability transition pore, or by adding alamethicin, will be accompanied by the release of all matrix space components up to a molecular weight of approximately 1,500 (42) . Thus potential activators will be diluted by about 10 such that the phosphorylated form was poorly active while activation occurred by dephosphorylation. This is because ATP (and other nucleotides) is released when the enzyme is activated by pore formation and would not be available to support a phosphorylated state. Also arguing against a poorly activated phosphorylated form, which becomes active upon dephosphorylation, is the failure of oligomycin to produce activation. This is because this agent, by inhibiting ATP synthesis, should antagonize the phosphorylation. If dephosphorylation was proposed to activate the enzyme following loss of membrane potential, because ATP synthesis is interrupted, then one is left to wonder why oligomycin alone would not have the same effect. Thus, while several potential activating mechanisms can be ruled out, several others remain. At present we favor a direct effect of membrane potential on the enzyme because it is straight forward and supported by the failure of oligomycin to produce an activation, and because it does not conflict with any of other available data on regulation of activity.
While deenergization is clearly required to observe activity in rat liver mitochondria, this may not be the case in mitochondria from all sources. Schnellmann and coworkers, examining kidney mitochondria from rabbit, found that uncoupling was not required (31). Brustovetsky and coworkers
showed that similar to kidney mitochondria, there is a background level of iPLA 2 activity observed in brain mitochondria without uncoupling. This level was increased by the presence of tBid plus full length Bax, possibly relating to ROS formation, and without requiring the permeability transition (32).
Williams and Gottlieb, who identified an iPLA 2 in rabbit heart mitochondria (28), used an activity assay based upon an artificial and exogenous substrate, which itself may affect bioenergetics status. They also obtained their mitochondria from perfused hearts which were subject to ischemia/reperfusion and/or ischemic preconditioning, which does indeed affect their biochemical properties [e.g. (43)]. Thus, it is not clear from that study if the heart mitochondrial enzyme is regulated similarly to the enzyme in liver mitochondria.
More recently, Gross and coworkers have described how multiple products can arise from the gene While it is clear that regulation of the mitochondrial iPLA 2 is not completely understood at the protein level, it can also be said that the same is true regarding the enzymes physiological and pathophysiological functions. We originally demonstrated that activity of the mitochondrial iPLA 2 promotes the permeability transition (26,27) and this has been verified and extended by other reports (31, 48) . That consequence of activity was expected, given the well established effects of FFA on the phenomenon (see Introduction). Thus to some degree, the question of mitochondrial iPLA 2 functions reduces to functions of the permeability transition. Apoptotic and necrotic cell death are prominent among the known functions of the transition and so the iPLA 2 is likely involved in those processes as well. In addition, it has long been maintained that the permeability transition, can be seen, in its most basic function, as a way to identify poorly functioning mitochondria within an intracellular population, and thereby to initiate their removal/replacement (35, 49, 50) . The present findings remain consistent with that role since even a modest depolarization produces an acceleration of iPLA 2 activity which would raise the probability that that the transition occurs in the affected mitochondrion (figure 6).
Numerous other functions of iPLA 2 have been suggested as summarized by others (33, 47, 51) .
Some of these reflect the generation of free arachidonic acid from phospholipids and its expected conversion to lipid signaling molecules, including prostaglandins, HETES, thromboxanes, and leukotrienes. Local circulation through capillaries is influenced by some of these and in particular it is increased by prostaglandins of the E series [e.g. (52, 53) ]. Given the graded response of iPLA 2 activity to decreasing membrane potential (figure 6C), and the reversibility of activation, once a full potential is restored (figure 5), one can imagine that this enzyme provides for a signaling mechanism between mitochondria and the local circulation as regards the adequacy of blood flow. If flow were not adequate to meet the needs for O 2 and substrates, the membrane potential would decrease proportionately, iPLA 2 activity would rise increasing the availability of arachidonate, and prostaglandins produced from some of this would cause dilation of nearby capillaries. Once the blood supply became sufficient, the membrane potential would rise and enzyme activity would return to a near zero value. With the availability of iPLA 2 knockout mice (54-56), this possibility, and others can be further investigated.
A final point to consider here is the partial inhibition of apparent iPLA 2 activity produced by the mechanism-based inhibitor BEL. This was seen when BEL is used as a racemic mixture and regardless of which electron transport inhibitor was used to bring about deenergization. More specifically we found that BEL reduced activity by about 50% when it was assessed at 1 hr after deenergization and the BEL had been added at the beginning of the incubation (figure 7). This partial sensitivity to BEL, (45, 48) . Those findings also allow for the participation of multiple enzymes in hydrolyzing mitochondrial phospholipids at the sn-2 position. In our first paper describing the presence of an iPLA 2 in liver mitochondria, we found that BEL eliminated about 85% of the activity (26). To explain that in light of the present finding we note that in the earlier paper the effectiveness of BEL was evaluated in media having a high ionic strength (KCl-based media). Total iPLA 2 activity is higher in those media than in the mannitol-sucrose media used here, but the BEL insensitive activity is about the same. Hence a larger fraction of total activity is inhibited by BEL at high ionic strength. We did not use high ionic strength in this study because mitochondria swell and lose cytochrome c during extended exposure to KCl-based media (27,58). Those changes are incompatible with goals which require that constant membrane potential be maintained on a time scale of hours. Further work will be required to establish the protein identity of the BEL insensitive activity.
In conclusion, while regulation of the mitochondrial iPLA 2 is not yet completely understood, data presented in this paper contribute to our understanding of how mitochondria likely respond to and modulate iPLA 2 , activity under physiological and pathophysiological conditions that produce changes in energization. The reversibility of enzyme activity upon re-energization as well as the graded nature of the activation with partial deenergization fit well with models of signaling and regulatory mechanisms. Animal to animal variation was determined from six repeat experiments using different mitochondrial preparations, which examined iPLA 2 after uncoupling with CCCP. The variation is similar when other approaches to deenergization are employed, as can be seen in Figure 7 . 4 We did not determine the destination of the free fatty acids that were lost upon reestablishing a membrane potential, which amounted to about 0.3 nmol/mg protein. We did notice, however, that the use of Percoll gradient purified mitochondria or the presence of BEL did not alter that behavior. 
